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Background: Heterochromatin protein 1 (HP1) is important in the establishment, propagation, and maintenance of
constitutive heterochromatin, especially at the pericentromeric region. HP1 might participate in recruiting and
directing Mis12 to the centromere during interphase, and HP1 disruption or abrogation might lead to the loss of
Mis12 incorporation into the kinetochore. Therefore, the centromere structure and kinetochore relaxation that are
promoted in the absence of Mis12 could further induce chromosome instability (CIN) by reducing the capacity of
the kinetochore to anchor microtubules. The aim of this study was to determine whether alterations in the
localization of HP1 proteins induced by trichostatin A (TSA) modify Mis12 and Centromere Protein A (CENP-A)
recruitment to the centromere and whether changes in the expression of HP1 proteins and H3K9 methylation at
centromeric chromatin increase CIN in HCT116 and WI-38 cells.
Methods: HCT116 and WI-38 cells were cultured and treated with TSA to evaluate CIN after 24 and 48 h of exposure.
Immunofluorescence, Western blot, ChIP, and RT-PCR assays were performed in both cell lines to evaluate the
localization and abundance of HP1α/β, Mis12, and CENP-A and to evaluate chromatin modifications during interphase
and mitosis, as well as after 24 and 48 h of TSA treatment.
Results: Our results show that the TSA-induced reduction in heterochromatic histone marks on centromeric chromatin
reduced HP1 at the centromere in the non-tumoral WI-38 cells and that this reduction was associated with cell cycle
arrest and CIN. However, in HCT116 cells, HP1 proteins, together with MIS12 and CENP-A, relocated to centromeric
chromatin in response to TSA treatment, even after H3K9me3 depletion in the centromeric nucleosomes. The
enrichment of HP1 and the loss of H3K9me3 were associated with an increase in CIN, suggesting a response
mechanism at centromeric and pericentromeric chromatin that augments the presence of HP1 proteins in those
regions, possibly ensuring chromosome segregation despite serious CIN. Our results provide new insight into the
epigenetic landscape of centromeric chromatin and the role of HP1 proteins in CIN.
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Heterochromatin protein 1 (HP1) binds to histone H3 pro-
teins that have been methylated at lysine 9 by SUV39H1,
thereby propagating the methylation along chromatin [1].
HP1 function is highly important for the establishment,
propagation, and maintenance of constitutive heterochro-
matin [2], especially at the pericentromeric region, which is
enriched with H3K9me3 and H4K20me3 marks, hypoace-
tylated H3 and H4, and highly methylated regions along
most of its satellite repeats [3,4]. Due to its juxtaposition
with centromeric chromatin, it has been suggested that the
organization and stability of the pericentromeric region are
crucial for correct chromosomal segregation during mitosis;
therefore, this region is important for genome stability [3,5].
HP1 also plays a role in centromeric sister chromatid
cohesion [6], telomere maintenance, and DNA repair [7].
In humans, these functions are performed in a specific
manner by each of the three identified HP1 subtypes:
HP1α, HP1β, and HP1γ [8,9]. HP1 protein localization dif-
fers in the interphase nucleus, with HP1α typically found
in pericentric and telomeric chromatin and HP1β nor-
mally found in heterochromatin regions [10].
Live cell microscopy analyses have demonstrated that
the localizations of human HP1α and HP1β have specific
functions at different points of the cell cycle. An exchange
between human HP1α and HP1β has been observed at
centromeric heterochromatin during mitosis [10]. This ex-
change is mediated by differences in the chromoshadow
domain sequences of these proteins [10]. Increasing evi-
dence has shown that the Knl1-Mis12-Ndc80 (KMN) pro-
tein complex is a binding partner of HP1 in humans, in
which HP1 might participate in recruiting and directing
Mis12, a kinetochore complex component that is a sub-
unit of the KMN network that resides at the centromere
during interphase and stably associates with the kineto-
chore during mitosis [11-13]. The disruption or abroga-
tion of HP1 is believed to lead to tumor formation, and
the absence of HP1 might also lead to the loss of Mis12
incorporation into the kinetochore. Therefore, the centro-
mere structure and kinetochore relaxation that are pro-
moted by the absence of Mis12 could further induce
chromosome instability (CIN) by reducing the capacity of
the kinetochore to anchor microtubules [14].
These findings suggest that the deregulation of epigenetic
components in the kinetochore complex could result in
chromosomal defects and CIN development. Furthermore,
it has become increasingly clear that chromatin compos-
ition affects centromere determination and establishment.
Nevertheless, the genomic and chromatin modifications
that are necessary to establish and maintain the centromere
remain unknown. It has been suggested that the DNA
sequence alone is not always sufficient for centromere
establishment or function [15], supporting theories that
postulate the involvement of epigenetic mechanisms [16].Thus, the aim of our study was to determine whether alter-
ations in the localization of HP1 proteins modify Mis12 re-
cruitment to the centromere and whether changes in the
expression of HP1 proteins and H3K9 methylation at
centromeric chromatin lead to an increase in CIN.
To address these questions, we evaluated HP1 proteins
during the cell cycle. In addition, we treated cells with tri-
chostatin A (TSA), an inhibitor of histone deacetylase
(HDAC) enzymes, to indirectly antagonize centromeric het-
erochromatin and HP1 binding by reducing H3K9me3
abundance. Our results show that the TSA-induced reduc-
tion in heterochromatic histone modification of centro-
meric chromatin reduced HP1 levels at the centromere in
WI-38 cells and that this reduction was associated with cell
cycle arrest and CIN. However, in HCT116 cells, HP1 pro-
teins relocated to centromeric chromatin in response to
TSA treatment, and this re-localization was induced even
after H3K9me3 was reduced in the centromeric nucleo-
somes. The enrichment of HP1 proteins in HCT116 cells
was associated with increased CIN, suggesting a response
mechanism in the centromeric and pericentromeric chro-
matin that augments the presence of HP1 proteins in those
regions, possibly ensuring chromosome segregation despite
serious CIN.
Results
Chromosome instability is induced by TSA
HP1 proteins and H3K9me3 have been shown to play an
important role in chromosome stability. There are sev-
eral reports on the different types of CIN promoted by
TSA treatment in a wide range of concentrations and
periods of exposure [17-19]. Therefore, we evaluated if
treatments with TSA promoted a similar effect in the in-
duction of CIN in WI-38 and HCT116 cells.
TSA induced aneuploidy in both cell lines (Figure 1A).
After TSA treatment for 24 h, 26% of WI-38 cells were an-
euploid, and this frequency was maintained for at least 48 h
post-treatment. In contrast, 47% of HCT116 cells were an-
euploid after TSA treatment for 24 h; however, this fre-
quency was lower (22%) after treatment for 48 h. WI-38
cells lost more than 6 chromosomes or gained more than
20 chromosomes (Figure 1B). A high number of HCT116
cells were aneuploid after 24 h of treatment; however, after
48 h, the rate of chromosomal gains and losses was reduced
(Figure 1C, Table 1). After TSA treatment for 24 h, 32% of
WI-38 cells were 4n; after treatment for 48 h, 19.6% of the
cells remained 4n, indicating that WI-38 cells could not
properly segregate following TSA treatment (Table 1). Only
4% of HCT116 cells were 4n after treatment for 24 h, and
no 4n cells were found after 48 h (Table 1).
Centromeric chromatin dynamics during the cell cycle
To observe the localization of HP1α and HP1β proteins
throughout the cell cycle, as well as their association
Figure 1 Trichostatin A (TSA) treatment generates chromosome instability primarily in HCT116 cells. Chromosome counting was
performed after cells were treated with 1 μM TSA for 24 and 48 h. (A) The percentage of aneuploidy was greater than 26% after the 24 and 48 h
TSA treatments in WI-38 cells, and the effect of TSA was more pronounced in HCT116 cells after 24 h (at 47%) but decreased to 21% after 48 h of
exposure. (B-C) The representation of the number of chromosomes from the controls and the 24- and 48-h TSA-treated WI-38 (B) and HCT116
cells (C), showing gains and losses after counting; the black line designates the 2n cells, and the dotted line designates the 4n cells. The total
number of chromosomes in 50 cells was counted. The Kruskal-Wallis test yielded p < 0.05 compared with the values of the control (CTR).
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fluorescence assays in WI-38 (Figure 2A) and HCT116
(Figure 3A) cells. In WI-38 cells, we explored the nuclear
localization of H3K9me3 and CENP-A, both of which were
enriched at centromeric loci and neighboring regions. This
enrichment persisted in mitotic cells (Figure 2A). Because
H3K9me3 is the epigenetic modification that is recognized
by the HP1 protein chromodomain, and given the import-
ance of HP1 proteins for proper chromosome alignment
and mitotic progression [11,19], we evaluated the nuclearTable 1 Analysis of total chromosome number in each cell aft
WI-38
Control 24 h* 48 h*,**
Mode 42 (87.5%) 21(42%) 28 (54.9%)
Loss 6 (12.5%) 8 (16%) 11 (21.56%)
Gain 0 5 (10%) 2 (3.92%)
4n 0 16 (32%) 10 (19.6%)
Total 48 50 51
Loss was considered below 2n, and gain was considered above 2n.
*Levene’s test p < 0.001; treatment versus control.
**Levene’s test p < 0.05; 24-h treatment versus 48-h treatment.localization of the HP1α and HP1β isoforms together with
CENP-A. We observed little difference in the localization
of both HP1 isoforms at the centromere. HP1α was local-
ized to regions neighboring CENP-A, which are likely peri-
centromeric heterochromatin, and also occupied other
chromatin regions. HP1β showed a similar localization pat-
tern (Figure 2A). Therefore, although both isoforms play a
critical role in establishing and maintaining heterochroma-
tin, they might play different roles in terms of the sur-
rounding centromeric chromatin.er 24 and 48 h of trichostatin A (TSA) treatment
HCT116
Control 24 h 48 h**
49 (96.08%) 25 (54.9%)* 40 (78.43%)
2 (3.92%) 14 (27.5%)* 7 (13.73%)
0 10 (19.6%)* 4 (7.84%)
0 2 (3.9%) 0
51 51 51
Figure 2 Centromeric localization of HP1α and HP1β in WI-38 cells under basal conditions and after TSA treatment. (A) WI-38 cell fluorescent
microscopy localization of CENP-A with H3K9me3 (lane 1), HP1α (lane 2-3) and HP1β (lane 4). (B) Chromatin localization by fluorescent microscopy in
WI-38 cells after TSA treatment comparing H3K9me3 with HP1α (lane 1) or HP1β (lane 2) H3K9ac with HP1α (lane 3) or HP1β (lane 4), the centromeric
localization of HP1α compared with CENP-A (lane 5), and HP1β compared with ACA (lane 6). The DNA is marked with DAPI; the images show the most
common distribution of proteins after the analysis of 100 cells (%); the boxes represent a magnification of the immunofluorescence results; M, mitotic cell.
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localization of H3K9me3, HP1α, and HP1β are conserved
in a cancer cell line with no CIN and with stablechromosome segregation such as HCT116 cells. For this
purpose, we performed immunofluorescence microscopy
assays to observe the centromeric localization of HP1.
Figure 3 Centromeric localization of histone marks, HP1α, and HP1β in HCT116 cells under basal conditions and after TSA treatment.
(A) HCT116 chromatin localization by fluorescent microscopy of CENP-A with H3K9me3 (lane 1) or HP1α (lane 2), H3K9me3 and HP1α (lane 3),
ACA and HP1β (lane 4), and HP1β and Mis12 (lane 5). (B) Centromeric localization of H3K9me3 and CENP-A (lane 1), CENP-A and HP1α (lane 2),
ACA and HP1β (lane 3) and Mis12 co-localization with HP1β (lane 4). The DNA is marked with DAPI; the images show the most common distribution
of the proteins after the analysis of 100 cells (%); the boxes represent a magnification of the immunofluorescent results; M, mitotic cell.
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during mitosis, it either co-localized or was enriched in
the region neighboring the centromere (Figure 3A). As
expected, the HP1 isoforms showed similar patterns of
localization in both cell lines, suggesting conserved chro-
matin behavior for both H3K9me3 and HP1 (Figure 3A).
We observed almost no co-localization of the euchromaticmarks H3K9ac and H3K4me2 with CENP-A, indicating
that open chromatin marks are present at centromeric re-
gions at a low frequency in both cell lines (Additional file 1:
Figure S1A-B). Considering that HP1 has been associated
with the Mis12 complex, we observed that HP1 co-
localizes with Mis12 during interphase, but this localization
changes slightly during mitosis (Figure 3A).
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matin and to assess its dynamics during interphase and
mitosis, we selected HCT116 cells with stable chromo-
somal segregation. We treated these cells with nocodazole
for 12 h and isolated the mitotic cells using the shake-off
method. We then performed a ChIP assay for activating
(H3K4me2 and H3K9ac) and repressive (H3K9me2/me3)
histone marks, as well as for CENP-A, Mis12, HP1α,
and HP1β, in mitotic and interphase cells. As controls for
open and closed chromatin, we evaluated the GAPDH
and WIF1 promoter regions, respectively. The GAPDH
promoter, as expected, was enriched with the markers of
gene activation H3K4me2 and H3K9ac; the abundance of
these marks was increased during mitosis, but the increase
was proportional to the gain in total H3 in the region
(Additional file 2: Figure S2A). We used the WIF1 gene
promoter region as a positive control for gene silencing
due to its role as a WNT inhibitor; this promoter is
known to be enriched with H3K9me2 and H3K9me3
modifications after cell differentiation during embryonic
development. We found that this region was enriched with
repressive marks and that these marks were increased dur-
ing mitosis (Additional file 2: Figure S2B).
Because centromeric chromatin has been poorly studied
by ChIP analysis and because there have been contrasting
results in different models, we designed primers for global
satellite-α repeats and analyzed the 171-bp monomer se-
quence. Our results showed that H3K9me2 and HP1β are
present during interphase and mitosis, whereas the pres-
ence of H3K4me2, H3K9ac and H3K9me3 histone marks
fluctuate throughout the cell cycle (Additional file 2:
Figure S2C).
However, the satellite-α repeat arrangement varies at the
centromere, and CENP-A/H3 nucleosomes are scattered
thorough the centromeric sequence. We therefore de-
signed primers that were specific for satellite-α and
satellite-2 regions of chromosome 1 to confine the analysis
of chromatin changes to these regions. We evaluated
chromosome 1 satellite-2 pericentromeric regions, which
were enriched with H3K9me2 and H3K9me3 during inter-
phase; as expected, HP1α and HP1β were also present
during this phase (Figure 4A-B) because satellite-2 is a
well-known heterochromatic region. Interestingly, we
observed a 2-fold enrichment of H3K4me2 and a 50% re-
duction of H3K9me3 in mitotic cells. We did not observe
Mis12 and CENP-A at the satellite-2 repeat. We then ques-
tioned whether the same modulation occurred in normal
cells such as WI-38 cells. We explored the same satellite-2
regions during interphase and mitosis and found that in
interphase cells, H3K9me3 was abundant alongside HP1α,
which is typical of the pericentromeric constitutive hetero-
chromatin domain (Figure 4C). During mitosis, H3K9me3
was reduced, but HP1α was heavily enriched, suggesting a
role for HP1α at pericentromeric heterochromatin duringchromosome segregation (Figure 4C). We observed an un-
expected enrichment of CENP-A at satellite-2 chromatin
during mitosis (Figure 4C).
Moreover, in the chromosome 1 satellite-α repeat region,
a mixed histone epigenetic landscape was found, in which
active and repressive histone marks were present through-
out the cell cycle (Figure 4D-E). We observed a significant
enrichment of CENP-A during mitosis, whereas the enrich-
ment of known H3 modifications was reduced (Figure 4D).
The satellite-α region in WI-38 cells was also enriched with
CENP-A and HP1α. Although H3K9me3 was reduced
during mitosis, it remained present at the centromere
(Figure 4F), suggesting that HP1α plays a different role at
the centromere in this cell line than in HCT116 cells. In
contrast to the immunofluorescence results, we detected
HP1α and HP1β in the specific satellite-α region, and their
enrichment fluctuated slightly during mitosis (Figure 4E-F).
TSA treatment causes HP1 proteins to re-localize to
centromeric chromatin in HCT116 but not WI-38 cells
To observe the effect of antagonizing heterochromatic
regions of pericentromeric and centromeric chromatin,
we treated WI-38 cells with 1 μM TSA, which leads to
chromatin relaxation and gene expression modulation
[20,21]. To evaluate the effect of TSA on the cell cycle,
cells were treated for 24 and 48 h; the drug was reintro-
duced via fresh medium every 24 h. The effect of this
treatment on protein nuclear localization was observed
by fluorescence microscopy. TSA reduced H3K9me3
levels, as expected, and also reduced the protein levels of
HP1α and HP1β (Figures 2A and 3B). Clear foci of
H3K9me3 remained after treatment, and these foci co-
localized with the HP1α and HP1β isoforms (Figures 2B
and 3B). We also observed that these HP1 protein foci
localized to the same regions occupied by CENP-A,
suggesting that both H3K9me3 and HP1α/β are more
enriched in the centromeric region, as defined by the
localization of CENP-A and ACA. These results suggest
that H3K9me3 was preserved at the centromere and that
both HP1 proteins accumulate at centromeric chromatin
in response to TSA treatment (Figures 2B and 3B).
When treated with TSA, both HCT116 and WI-38 cells
presented H3K9me3 at CENP-A foci, which were also
occupied by both HP1 isoforms (Figures 2B and 3B).
Considering that HP1 has been associated with the
Mis12 complex, we determined whether Mis12 localization
was affected by TSA. Interestingly, Mis12 localization
showed a strong correlation with HP1β localization and
was also enriched at TSA-promoted HP1β foci, suggesting
that this kinetochore foundation protein is associated with
HP1β not only during mitosis but also during interphase
(Figure 3B).
To determine whether these changes in HP1 protein
localization were related to alterations in total protein
Figure 4 Epigenetic changes and protein dynamics at satellite-2 and satellite-α regions during interphase and mitosis in HCT116 and
WI-38 cells. qRT-PCR analysis of the satellite-2 (A-C) and satellite-α (D-F) repeats was performed on DNA obtained from anti-H3K4me2,
H3K9me2, H3K9me3, H3K9ac, HP1α, HP1β, Mis12 and CENP-A ChIP assays in interphase (black) and mitotic (gray) cells. Normal rabbit IgG was
employed as a negative control. ★p < 0.05 and ★★p < 0.01 represent significant differences between interphase and mitosis, as evaluated by
Student’s T-test.
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types before and after the TSA treatments for 24 and
48 h. After 24 h, we observed a significant reduction in
HP1α in HCT116 cells only; no significant changes were
found in WI-38 cells. After 24 h of TSA exposure, HP1β
was decreased in WI-38 cells; however, the original
levels were restored after 48 h. No changes were ob-
served in the abundance of HP1β in HCT116 cells or
the levels of CENP-A in either cell line after TSA treat-
ment (Figure 5). Moreover, we found no significant
changes in H3K9ac levels after TSA treatment, although
we did observe a tendency to accumulate acetylation
after 48 h of treatment in WI-38 cells. Nevertheless,
H3K9me3 levels were significantly decreased, especially
after 48 h of TSA exposure, suggesting not only that
TSA decreased this heterochromatin mark but also that
TSA-promoted acetylation did not significantly affect
H3K9 residues (Figure 5). One possible explanation is
that acetylation might occur at a higher frequency on
other H3 or H4 lysine residues. Taken together, our re-
sults suggest that the changes in HP1 localization are
most likely due to the reduction in H3K9me3 after TSA
treatment rather than to alterations in HP1 protein
translation.
TSA treatment leads to changes in the nuclear loca-
lization of HP1 proteins. Therefore, we performed a ChIP
assay after TSA exposure in HCT116 cells. We found that
TSA abolished the abundance of H3K9me3 at satellite-2regions after the first 24 h of treatment; this abolishment
was associated with the loss of HP1α and HP1β after 24 h
of TSA exposure (Figure 6A-B). Surprisingly, HP1α and
HP1β were reestablished at satellite-2 chromatin after
48 h of TSA exposure, even though H3K9me3 was dra-
matically diminished by the treatment (Figure 6A-B).
H3K4me2 and H3K9ac were not significantly changed
after 24 h of treatment, but were significantly increased
after 48 h (Figure 6A), suggesting that TSA treatment pro-
motes a significantly open chromatin state at the satellite-
2 region after 48 h of exposure.
Satellite-α, in addition to satellite-2, regions exhibited
losses in H3K4me2, H3K9me3, and H3K9ac after 24 h of
TSA treatment. However, after 48 h, H3K4me2 was re-
stored to the centromere, whereas H3K9ac was signifi-
cantly increased (Figure 6D). Although H3K9me3 was
significantly reduced by the TSA treatment, some fraction
of this mark remained at the centromere (Figure 6D).
After 24 h of treatment, CENP-A was increased by 10-fold
at satellite-α chromatin and remained enriched by 10-fold
after 48 h of TSA treatment (Figure 6E). As observed in
the immunofluorescence experiments, HP1α and HP1β
were enriched 6- and 4-fold, respectively, and this fold en-
richment was proportional to the fold increase in Mis12 at
satellite-α chromatin, suggesting that the presence of
Mis12 was associated with the abundance of HP1 at the
centromere (Figure 6E). We used the GAPDH gene pro-
moter as a control to evaluate the effect of TSA treatment.
Figure 5 The protein content in HCT116 and WI-38 cells treated with TSA. Representative Western blot of HP1α, HP1β, H3, H3K9me3,
H3K9ac and CENP-A levels after treatment with 1 μM TSA for 24 or 48 h. The experiments were conducted in 3 independent determinations that
were performed in duplicate for each experimental condition; the asterisk indicates p < 0.05 compared with the value of the control (CTR), as
obtained by Student’s t-test.
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observe a loss of H3K9me3 as a result of the treatment,
suggesting that H3K9ac is not essential for GAPDH up-
regulation (data not shown).
Because HCT116 cells showed changes in histone
marks and HP1 protein levels after TSA treatment, we
next questioned whether the same modulation occurred
in normal cells. Therefore, we treated WI-38 cells with
TSA for 24 and 48 h and performed a ChIP assay using
antibodies against H3K9me3, CENP-A, and HP1. TSA
treatment for 24 h reduced H3K9me3 levels in satellite-
2 regions and nearly abolished this histone mark after
48 h. Therefore, HP1α was reduced as its reader mark
was diminished (Figure 6C). In contrast to the observa-
tions made in HCT116 cells, after 24 h of exposure to
TSA in WI-38 cells, HP1α and HP1β were reduced at
the satellite-α region and were not reestablished after
48 h, even though H3K9me3 levels were reestablished
(Figure 6F). This result suggests that the co-localization
observed by immunofluorescence was located at specific
centromeric and pericentromeric chromatin regions and
not at the chromosome 1 centromeric region.Discussion
HP1α and HP1β localize at centromeric regions after TSA
exposure in HCT116 cells, but their levels are reduced in
WI-38 cells
In different cell lines and animal models, aberrant mitotic
phenotypes have been attributed to a lack of pericentro-
meric H3K9me3, changes in H4K20me, and abnormal
regulation of HDAC. CIN has been observed as increased
chromosome misalignment in metaphase, nondisjunction
in anaphase, and lagging chromosomes in telophase, and
as high rates of aneuploidy and the appearance of micro-
nuclei during cytokinesis or early G1 phase [17,22,23].
HP1 is essential, especially in the pericentromeric re-
gion, which is enriched with H3K9me3 and H4K20me3
modifications, hypoacetylated H3 and H4, and highly
methylated regions along satellite repeats [4,24,25]. Little
is known regarding the effects of HP1 during mitosis;
however, the reduction of HP1 by TSA-promoted mi-
totic defects has been previously reported [18,20]. We
observed that HP1α and HP1β, together with H3K9me3,
are located in pericentromeric regions and that the
centromeric localization of HP1 is preserved during
Figure 6 Epigenetic changes and protein dynamics at satellite-2 and satellite-α regions after treatment with TSA for 24 and 48 h in
HCT116 and WI-38 cells. qRT-PCR analysis of the satellite-2 (A-C) and satellite-α (D-F) repeats was performed on DNA obtained from anti-H3K4me2,
H3K9me3, H3K9ac, HP1α, HP1β, Mis12 and CENP-A ChIP assays in untreated cells (Black bar) and TSA-treated cells for 24 (white bar) or 48 h (gray bar).
Normal rabbit IgG was employed as a negative control. ★p < 0.05 and★★p < 0.01 indicate significant differences between treated and untreated cells,
as evaluated by Student’s t-test.
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other regions of the chromosome. Likewise, we observed
changes in HP1α and HP1β abundance throughout the
cell cycle at the centromeric and pericentromeric chroma-
tin of chromosome 1. This result was consistent with a
previous report in which HP1 proteins underwent large-
scale dissociation in G2-phase cells [26]. The change in
HP1 localization during mitosis could also be attributed to
the presence of acetylated histones on mitotic chromo-
somes, which decreases the accessibility of histone N-tails
to the antibody, as was observed for H3 serine 10 phos-
phorylation [18,27].
Centromeres contain CENP-A nucleosomes interspersed
with H3K9me2/3 nucleosomes but exhibit low levels of
H3K4me2 enrichment [28,29]. In this regard, we observed
clear HP1-enriched foci co-localizing with CENP-A and
H3K9me3 during interphase; this colocalization continued
throughout mitosis. In HCT116 cells, we found that
H3K4me2 is reduced at centromeric chromatin during mi-
tosis. It has been reported that H3K4me2 is an essential
modification of centromeric chromatin that is required for
its long-term maintenance and function, whereas the en-
richment of H3K9me3 and H3K9ac fluctuate significantly
throughout the cell cycle [22]. H3K9me3 has been re-
ported to increase in abundance during G2/M in mam-
mals, whereas H3K9me2 abundance remains constant
during the cell cycle [22,30,31]. Our results are consistent
with an increase in H3K9me3 at satellite-2 chromatin and
at non-specific satellite-α regions; moreover, no significant
increase was detected at satellite-α regions upon analyzingchromosome 1 during mitosis. Remarkably, these results
suggest that H3K9me3 abundance at satellite-2 regions
during mitosis is not equal in all cells, as was previously
suggested.
Increasing evidence has shown that the KMN network
in humans is a binding partner of HP1 and that HP1
may participate in recruiting and directing the Mis12
complex to the centromere during interphase by direct
interaction with Mis14 [11,12,32]. In HCT116 cells, we
observed that during interphase, HP1α, HP1β and Mis12
are present at centromeric chromatin, in agreement with
previous reports. In contrast, during mitosis, Mis12 was
not enriched at the same site, although HP1α and HP1β
were also reduced. This could be explained by the nature
of the Mis12 interaction with HP1: HP1α and Ndc80 are
competitive binders of Mis12, suggesting that these pro-
teins have identical or overlapping binding sites [13]. For
the Ndc80 complex to localize to the kinetochore, it is
necessary to displace most of the HP1α from Mis12. As
a result, Mis12 and the Ndc80 complex play a role at the
outer kinetochore but not at mitotic centromeric chro-
matin during metaphase.
TSA induces differential changes in centromeric and
pericentromeric chromatin and in CIN induction in HT116
and WI-38 cells
TSA treatment promotes histone hyperacetylation, which
becomes visible at the nuclear periphery, as well as the re-
duction of many heterochromatin regions in the nucleus
[20,33,34]. Due to this reduction of heterochromatin, we
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centromeric and pericentromeric regions due to HP1 pro-
tein enrichment. We found that both HP1α and HP1β
were enriched in foci that co-localized with H3K9me3 and
CENP-A, suggesting that both HP1 proteins not only
remained at pericentromeric heterochromatin but were
also enriched at constitutive heterochromatin and ex-
panded to centromeric chromatin. This result is similar to
the findings of a study conducted in HeLa cells after
short-term TSA treatments [20]. We also observed that
H3K9me3 modifications and HP1 proteins are generally
reduced in the nuclei after TSA treatment in HCT116
cells. Interestingly, this result is contradictory to a recent
report in which HP1 protein localization to centromeric
chromatin was reduced and scattered in the nucleus after
the treatment of murine cell lines with low concentrations
of TSA [35]. In this regard, it has been observed that upon
inhibition of heterochromatin acetylation, HP1 disperses
within the nucleus. Another report observed that HDAC
inhibition caused the dynamic recruitment of HP1 pro-
teins to pericentromeric chromatin in a primary human
cell line, suggesting that HP1 mobilization after treatment
could protect the kinetochore structure and function and
that HP1 proteins behave differently in human and mouse
cells [19,35-37].
TSA could influence histone acetylation at pericentro-
meric heterochromatin regions, as reported for low doses
in other cell models, but requires several cell cycles to take
effect [20]. In contrast, following short-term treatment
with 1 μM TSA, we observed that HP1α and HP1β reloca-
lized to centromeric chromatin, where H3K9me3, al-
though reduced, was still present during interphase and
mitosis in both normal and transformed cells. Our result
is in contrast with the results of other reports indicating
that, whereas H3K9ac was increased at the satellite-III
region, the abundance of H3K9me2/me3 after treatment
with TSA for 15 h TSA or with other HDACi treatments
was not changed [19,38]. These results suggest that the
chromatin at pericentromeric and centromeric regions
responded differently to TSA treatment.
We observed that Mis12 localization appears to be in-
trinsically associated with HP1β during the cell cycle.
Remarkably, this phenomenon did not occur in normal
cells, and H3K9me3 levels were nearly unaffected by
treatment, whereas both HP1 proteins, together with
CENP-A, were reduced, suggesting that the mechanism
that promotes HP1 protein localization to the centro-
mere in HCT116 cells fails in WI-38 cells.
It has been suggested that the inhibition of histone
deacetylation before mitosis is associated with improper
chromosome condensation, which might induce mitotic
checkpoint activation and CIN [18,20,39]. Such inhib-
ition at the pericentromeric region might lead to defi-
cient kinetochore assembly during mitosis [20,21,39].However, such effects upon the kinetochore compos-
ition and microtubule dynamics were observed without
an effect on Mis12 [39]. Although we agree that Mis12
was not globally affected, Mis12 was enriched at the
centromeric chromatin of chromosome 1 after TSA ex-
posure, indicating that the effect on Mis12 is more fine-
tuned.
TSA treatment induced aneuploidy in both cell types.
We observed that the cytotoxic effects of TSA were more
pronounced in HCT116 cells than in WI-38 cells. Add-
itionally, we found a significant percentage of tetraploid
cells after TSA exposure in WI-38 cells. One reason for
the cytotoxicity of TSA used at high doses is thought to be
the disruption of two cell-cycle checkpoints: the G2 phase
checkpoint and the mitotic spindle checkpoint [40,41].
This dual checkpoint disruption results in the premature
exit of cells from mitosis, possibly followed by apoptosis; it
has been reported in HeLa cells that treatment for 24 h
with 1 μM TSA induced apoptosis in approximately 20%
of cells [33]. Therefore, we suggest that this cell death is
caused by aneuploidy because TSA decreases proliferation
and promotes apoptotic cell death by inducing caspase 3/
7 activity [42]. However, a recent report in murine fibro-
blastic NIH 3 T3 cells observed significant effects on the
mitotic index and micronuclei induction only upon treat-
ment of high concentrations of HDACi for 48 h [35]. A
similar phenomenon might be occurring in WI-38 cells,
wherein these cells might be more resistant to TSA than
HCT116 cells.
We show that differential changes in centromeric chro-
matin occur in HCT116 and WI-38 cells in response to
TSA. Based on this result, together with the reduction of
heterochromatin markers in pericentromeric chromatin
regions, we propose the model shown in Figure 7, in
which untreated HCT116 and WI-38 cells present a simi-
lar distribution of HP1 proteins and chromatin modifica-
tions at the centromeric and pericentromeric regions.
However, after TSA treatment, H3K9me3 was reduced,
whereas H3K9ac and CENP-A were increased at pericen-
tromeric and centromeric chromatin in both cell lines.
Furthermore, in HCT116 cells, HP1 proteins were recov-
ered to the pericentromeric and centromeric regions re-
gardless of the status of the reader mark. Suggesting that
an unknown mechanism that could include other proteins
or could involve an non-coding RNA transcript might be
recruiting HP1 proteins [43-45]. In contrast, in WI-38
cells, the HP1 proteins were lost from centromeric chro-
matin after treatment. CIN occurred after TSA treatment,
especially in HCT116 cells, in which very low levels of cell
cycle arrest were promoted compared with those in WI-
38 cells. These results suggest that the epigenetic land-
scape of centromeric and pericentromeric chromatin leads
to the differential promotion of CIN upon TSA treatment
in tumoral and non-tumoral cell lines.
Figure 7 The effect of TSA exposure on HP1α/β localization and centromeric and pericentromeric chromatin modifications, as well as
on the relationship with CIN in WI-38 and HCT116 cells. Upper panel: Untreated WI-38 and HCT116 cells presented a similar localization of
HP1α and HP1β along centromeric (CC) and pericentromeric chromatin (PC). At PC, H3K9me2/3 were enriched together with HP1 proteins; at CC,
CENP-A was enriched during mitosis, whereas H3K4me2, H3K9me2/3 and H3K9ac modifications, as well as HP1α and HP1β and Mis12 proteins,
fluctuate through interphase and mitosis. Lower panel: After treatment of HCT116 cells with TSA, H3K9me3 was significantly reduced at PC and
CC, resulting in increased H3K4me2 and H3K9ac at PC satellite-2 regions; HP1α/β were initially significantly reduced. However, they later recovered
by an unknown mechanism that could include other proteins or could involve an ncRNA PC transcript [43-45]. CC was enriched with H3K9ac and
CENP-A, together with HP1α/β and Mis12 proteins. HCT116 cells proliferated with low levels of cell arrest and exhibited CIN in 50% of the cells. In
both WI-38 and HCT116 cells, PC presented reduced H3K9me3, whereas H3K9ac and HP1 were enriched; moreover, CC was depleted of CENP-A
and HP1, and no significant reduction in H3K9me3 was observed, even though H3K9ac was increased. While CIN was still generated, it was
reduced compared with HCT116 cells.
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The data presented here provide new insight into the epi-
genetic landscape of centromeric chromatin, as well as
into the role of HP1α and HP1β proteins in chromosome
segregation and, by extension, cell division stability. We
also present evidence of differences in the organization of
centromeric chromatin and HP1 localization in response
to TSA in the WI-38 and HCT116 cell lines. These dif-
ferences are associated with CIN resulting from a chroma-
tin disturbance caused by reduced H3K9me3 levels and
TSA-induced hyperacetylation. The effects of TSA weresubstantially more pronounced in the malignant, trans-
formed HCT116 cells than in WI-38 cells, leading to more
significant chromosome mis-segregation and CIN. In
addition, we believe that one cause underlying the effects
of TSA-induced CIN and cell cycle arrest might be the de-
regulation of centromeric and pericentromeric chromatin
regions, leading to the possibility that epigenetic regula-
tion of the centromere might alter the response of tumor
cell lines to TSA treatment. Nonetheless, many questions
remain regarding the nature of centromere epigenetics,
how these epigenetic modifications regulate kinetochore
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well as how communication is established between centro-
meric and pericentromeric chromatin.
Materials and methods
Antibodies
The following antibodies were used: anti-ACA (immuno-
fluorescence (IF) dilution 1:200; Antibodies Incorporated,
Davis, CA, USA 15-235-F); anti-Mis12 (C-13; IF dilution
1:80, ChIP 4 μg; Santa Cruz, Santa Cruz, CA, USA sc-
107750); anti-H3K4me2 (IF dilution 1:200, ChIP 3 μg;
Millipore Temecula, CA, USA 07-030); anti-H3K9ac (IF
dilution 1:200, ChIP 2.4 μg; Abcam, Cambridge, MA, USA
ab10812); anti-H3K9me2 (IF dilution 1:200, ChIP 3 μg;
Abcam, ab1220), anti-H3K9me3 (WB dilution 1:250;
Abcam, ab8898; IF dilution 1:200, ChIP 3 μg; Diagenode,
Denville, NJ, USA CS-056-050); anti-CENP-A (IF dilution
1:200, ChIP 5 μg; Abcam, ab13939); anti-HP1α (IF dilu-
tion 1:100, ChIP 4 μg; Abcam, ab77256); anti-HP1β (IF
dilution 1:100, ChIP 4 μg; Abcam, ab10811); anti-GFP
(ChIP 4 μg; Abcam, ab290); and anti-H3 N-terminal (ChIP
1.5 μg; Sigma, St. Louis, MO, USA, H9289-200 μl).
Cell viability (IC50) after TSA treatment
Human WI-38 and HCT116 cells were obtained from
ATCC (CCL-75 and CCL-247). All cell lines were tested
and authenticated and were maintained in Eagle’s Mini-
mum Essential Medium (EMEM; ATCC) and McCoy
(Gibco) medium, respectively, supplemented with 10%
fetal bovine serum (Gibco) and antibiotics; the cells were
incubated at 37°C in a 5% CO2 atmosphere. The cells were
treated with TSA (Sigma, T8552-5MG) at 37°C for 24 and
48 h. IC50 concentrations were determined by plating
80,000 cells in 24-well dishes containing 0.5 ml of medium
and incubating overnight at 37°C; TSA was added when
cultures reached 80% confluence. Cells were washed with
PBS and fixed with 70% ethanol at -20°C, then washed in
PBS and stained with 1% crystal violet. After washing, the
stain was solubilized in 33% acetic acid, and the absorbance
was determined in an ELISA reader at 570 nm. The ana-
lyses were performed in triplicate in three independent ex-
periments. The IC50 values were calculated by linear
regression analysis of the dose-response data using the
points in the exponential region of the curve. The concen-
trations used for the TSA experiments were below the IC50:
4.9 μM for HCT116 cells and 9.4 μM for WI-38 cells.
Immunofluorescence
WI-38 and HCT116 cells were grown on 18-mm glass
coverslips (PEARL 7201) with EMEM (ATCC) and McCoy
medium (Gibco), respectively, supplemented with 10%
fetal bovine serum (Gibco) and antibiotics, and the cells
were incubated at 37°C in a 5% CO2 atmosphere. The cell
lines were fixed with 2% paraformaldehyde (PFA) in 1XPBS (pH 7.4) for 10 min, followed by permeabilization in
0.4% IGEPAL (Sigma CA-630) in PBS for 10 min at room
temperature and incubated with 0.5% BSA blocking buffer.
For each pair of primary antibodies, the optimal order of
addition was determined in preliminary experiments.
With the exception of ACA, which was visualized with
a fluorescein-conjugated secondary antibody, the fluo-
rophores on the secondary antibodies were Alexa Fluor
488-conjugated (Invitrogen, Life Technologies, México;
A11001 anti-mouse, A11008 anti-rabbit, and A11078
anti-goat) for green fluorescence and Cy3-conjugated
(Millipore, Temecula, CA, USA; AP124C anti-mouse and
AP1132C anti-rabbit) for red fluorescence. Following in-
cubation with the primary and secondary antibodies, DNA
was stained with DAPI. The cells were observed by fluor-
escence microscopy using a Zeiss Axio Imager A2 (Carl
Zeiss®, Germany); the images were analyzed using the soft-
ware AxioVision 4.8 (Carl Zeiss®, Germany). The cells
were also observed by laser confocal microscopy using a
Zeiss LSM 710 Duo (Carl Zeiss®, Germany); the images
were analyzed using the Zen 2008 software (Carl Zeiss®,
Germany).
TSA treatment
Exponentially growing HCT116 and WI-38 cells were
cultured on glass coverslips for 24 and 48 h in medium
containing 1 μM/ml TSA (Sigma, T8552-5MG), with
daily media changes. The cells were washed with PBS,
fixed with PFA, and used for immunofluorescence ana-
lysis, as described above. For treated chromatin isolation,
WI-38 and HCT116 cells were cultured on 100-mm cul-
ture plates and treated in the same manner as the cell
cultures grown on glass coverslips. We used 1 μM TSA
for 24 h and 48 h because at this concentration, we
found a significant induction of CIN or centromeric
chromatin remodeling. In addition, this concentration
was below the IC50 for both cell lines.
Electrophoresis and immunoblotting
After treatment with TSA, WI-38 and HCT116 cells were
harvested in lysis buffer containing 50 mM Tris-HCl
pH 7.5, 150 mM NaCl, 1% Nonidet P40, 0.5% deoxycho-
late, and the cOmplete Protease Inhibitors Cocktail
(Roche) and were then sonicated. Then, 30 μg of protein
was loaded onto a denaturing 10-20% gradient or 16% so-
dium dodecyl sulfate (SDS)-polyacrylamide gel and subse-
quently transferred to a nitrocellulose membrane. After
incubation for 2 h in a PBS solution containing 5%
albumin, the blots were exposed to the following primary
antibodies: anti-HP1α (1:300); anti-HP1β (1:200); anti-
H3 N-terminal (1:300); anti-H3K9me3 (1:250); anti-
H3K9ac (1:250); and anti-CENP-A (1:200). The blots were
incubated for 1 h at room temperature with the following
horseradish peroxidase-conjugated secondary antibodies:
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IgG (1:15,000 Santa Cruz Biotechnology, Inc.); and chick
anti-goat IgG (1:15,000 Chemicon International). The signal
was subsequently detected by chemiluminescence (ECL kit
from Millipore, USA) on Kodak X-Omat film. For the nega-
tive control, the primary antibody was omitted.
Chromatin immunoprecipitation (ChIP)
The ChIP assay was performed using the OneDay ChIP
kit (Diagenode, NJ, USA, Kch-onedIP-180), following the
manufacturer’s instructions. For all experiments, at least
two chromatin preparations from independent controls
and TSA-treated cells were analyzed. To obtain mitotic
and interphase cell chromatin, control and TSA-treated
cells were exposed to 2 μg/ml nocodazole for 12 h; the mi-
totic cells were isolated by the shake-off method, and
fluorescence-activated cell sorting (FACS) was used to se-
lect the population with 90% enrichment of mitotic cells.
Using this method, the interphase cells remained on the
culture plates and were harvested separately from the mi-
totic cells. Chromatin from each cell population was fixed
with 1% formaldehyde, and the cells were counted to en-
sure that 1x106 cells were used for each IP. The chromatin
was then extracted, and ChIP was performed following
the manufacturer’s instructions. As a negative control, we
used a normal rabbit IgG antibody (sc-2027, Santa Cruz
Biotechnology, USA).
The obtained results represent experiments from three
separate amplifications that were used to calculate the
standard deviation. To balance any difference in the
amounts of ChIP products and input for qPCR, the
amplification efficiency (AE) was calculated to within
10% of the input. The fold of the enrichment was calcu-
lated from the AE of specific experimental amplicons
against the AE of the background IgG amplicon, which
was amplified in triplicate by a fast optical 96-well qPCR
reaction plate (Applied Biosystems). The qPCR reaction
was performed using Thermo Maxima SYBR Green/
ROX 1 PCR Master Mix (Thermo Scientific, K0222)
with a StepOnePlus Real–Time PCR System (Applied
Biosystems, 4376600). Total H3 immunoprecipitation
was used to calibrate the increase in enrichment gener-
ated by chromosome duplication during mitosis.
ChIP primers
The primers used for the ChIP qPCR analysis were as fol-
lows: 5′- TCGTTCCCAAAGTCCTCCTGTTTC-3′ (Fwd)
and 5′-TCCGCAGCCGCCTGGTTC-3′ (Rev) for the
GAPDH promoter; 5′-AGCCCTTCCCGCTCTTCTGTT-
3′ (Fwd) and 5′-CGGCAGAGACGTAAGACTGGCAAA-
3′ (Rev) for the WIF1 promoter; 5′-ATCGAATGGAAAT
GAAAGGAGTCA-3′ (Fwd) and 5′-GACCATTGGAT
GATTGCAGTCA-3′ (Rev) for human chromosome 1
juxtacentromeric satellite-2 (Abcam, ab85781); 5′-AAGGTCAATGGCAGAAAAGAA-3′ and 5′-CAACGAAGGCCA
CAAGATGTC-3′ (Abcam, ab85782) for human chromo-
some 1 centromeric satellite-α; and 5′-GAAGTTTCTGA
GAATGCTTCTG-3′ (Fwd) and 5′-CTCACAGAGTT
GAACCTTCC-3′ (Rev) for the satellite-α 175-bp
monomers.
Chromosome spread and counting
WI-38 and HCT116 cells were cultured on 22×22-mm
glass coverslips until 70% confluence was reached; the
cells were then treated with TSA for 24 or 48 h. The cul-
ture medium was removed and replaced with fresh
medium after 24 h. The cells were treated for 3 h with
80 ng/ml colcemid (KaryoMAX GIBCO, USA 15210-
040) to induce mitotic arrest and then incubated for
30 min at 37°C in hypotonic buffer (75 mM KCl) that
had been pre-warmed to 37°C. The cells were fixed with
three 2-minute washes in a 3:1 methanol:acetic acid so-
lution and air-dried. The G banding standard protocol
was performed with trypsin-Giemsa solution to stain mi-
totic chromosomes. For each condition, a certified cyto-
geneticist evaluated 50 metaphases in duplicate.
Statistical analyses
Statistical significance was determined using Student’s t-
test or one-way analysis of variance (ANOVA). All of the
results are expressed as the mean ± SEM, and we used a
significance value of p < 0.05. We performed Levene’s
test to compare the significance of the control versus the
24- and 48-h TSA treatments or the 24- versus the 48-h
TSA treatment, with a significance value of p < 0.05 in
the metaphase counting analysis. Statistical analysis was
performed using the GraphPad Prism 5 software®.
Additional files
Additional file 1: Figure S1. Localization of H3K4me3, H3K9ac and Mis12
in WI-38 and HCT116 cells under basal conditions. (A) WI-38 cell
fluorescent microscopy images of the localization of CENP-A with
H3K4me2 (lane 1) and H3K9ac (lane 2). (B) Chromatin localization by
fluorescent microscopy of CENP-A with H3K4me2 (lane 1) and H3K9ac
(lane 2). DNA is marked with DAPI; the images show the most common
distribution of the proteins after the analysis of 100 cells (%); the boxes
represent a magnification of the immunofluorescence results; M,
mitotic cell.
Additional file 2: Figure S2. Chromosome immunoprecipitation controls
for active and repressive epigenetic marks during interphase (black) and
mitosis (gray). (A) The GAPDH gene promoter was analyzed for open
chromatin state marks. (B) The WIF1 gene promoter was analyzed for
repressive marks. (C) The epigenetic landscape was observed using changes
to the satellite-α repeat consensus sequence during the cell cycle. Changes in
the enrichment of H3K4me2, H3K9me2/3, H3K9ac, HP1α, HP1β, Mis12 and
CENP-A are shown. ★p < 0.05, ★★p < 0.01 indicate significant differences
between interphase and mitosis, as evaluated by Student’s t-test.
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